Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

Not Applicable

Not yet recruiting

• Conditions: PSA Changes After TURP
• Interventions: Procedure: TURP

• Registration Number: NCT05533047
• Lead Sponsor: Assiut University

Brief Summary

To use PSA levels after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia as an indicator of the quality of resection .

Detailed Description

PSA is a protein produced from the prostate epithelium and secreted in semen in huge amounts , small amount find its way to the circulation ,its function is to allow mobility of the sperms by interacting with the Semenogelin . clinical BPH can be defined as prostate adenoma/adenomata, causing a varying degree of BOO, which may eventually cause harm to the patients ,Treatment of this condition varies from conservative, medical and surgical depending on factors related to the patient and the surgeon preference . The early reports of minimally invasive treatment of the prostate dated back to 1937, since then and remarkable development is noticed . TURP is the golden treatment in the BPH . Studies compare between the methods according the blood transfusion , operation time retention after catheter removal , urethral complications , TUR syndrome and hospital-stay which show that bipolar is better. To our knowledge after few studies compare between the techniques according PSA also these studies show weakness in their statistically analysis with no difference between the methods .investigators aim is to study the effect of the operations on PSA levels as an indicator of the quality of resection.

Study Timeline

• Status Verified: 2022-09
• Study First Submitted: 2022-09-05
• Study First Submitted QC: 2022-09-07
• Last Update Submitted: 2022-09-07
• Study First Posted: 2022-09-08
• Last Update Posted: 2022-09-08
• Study Start: 2022-10-01
• Primary Completion: 2023-10-01
• Study Completion: 2023-11-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Male
• Target Recruitment: 2

Inclusion Criteria

• Patients agreeing to participate, clinically fit, age from 50 to 80 years with LUTS related to benign prostate enlargement with no neurological disorder

Exclusion Criteria

• Prostate cancer
• Previous urethral or prostate surgery
• Neurogenic bladder
• Urethral stricture
• Patient unfit for surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Monopolar TURP	TURP	Patients thats will undergo monopolar TURP
Bipolar TURP	TURP	Patients thats will undergo bipolar TURP

Primary Outcome Measures

Name	Time	Method
serum PSA changes after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia	within one month after intervention	To use PSA levels changes after both techniques (bipolar and monopolar transurethral resection of the benign prostatic hyperplasia)as an indicator of the quality of resection

Secondary Outcome Measures

Name	Time	Method
International Prostate Symptom Score	within one month after intervention	International Prostate Symptom Score after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia